These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 32739037)

  • 41. Survival analysis of recurrent breast cancer patients using mix Bayesian network.
    Shahmirzalou P; Khaledi MJ; Khayamzadeh M; Rasekhi A
    Heliyon; 2023 Oct; 9(10):e20360. PubMed ID: 37780765
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Meningioma and breast cancer: survival of patients with synchronous and metachronous meningioma and breast cancer.
    Lavrador JP; Pinto MV; Lemos LM; Ribeiro C; Santos AP
    J Neurooncol; 2018 Jan; 136(1):163-171. PubMed ID: 29119423
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Associations between adjuvant radiotherapy and different causes of death in a German breast cancer cohort.
    Obi N; Eulenburg C; Seibold P; Eilber U; Thöne K; Behrens S; Chang-Claude J; Flesch-Janys D
    Breast; 2018 Apr; 38():75-80. PubMed ID: 29248876
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Application of Bayesian network modeling to pathology informatics.
    Onisko A; Druzdzel MJ; Austin RM
    Diagn Cytopathol; 2019 Jan; 47(1):41-47. PubMed ID: 30451397
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Usefulness of Bayesian Network in Assessing the Risk of Triple-Negative Breast Cancer.
    Huang Y; Zheng C; Zhang X; Cheng Z; Yang Z; Hao Y; Shen J
    Acad Radiol; 2020 Dec; 27(12):e282-e291. PubMed ID: 32035756
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Probabilities of dying from cancer and other causes in French cancer patients based on an unbiased estimator of net survival: a study of five common cancers.
    Charvat H; Bossard N; Daubisse L; Binder F; Belot A; Remontet L
    Cancer Epidemiol; 2013 Dec; 37(6):857-63. PubMed ID: 24063904
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Semiparametric proportional odds models for spatially correlated survival data.
    Banerjee S; Dey DK
    Lifetime Data Anal; 2005 Jun; 11(2):175-91. PubMed ID: 15938545
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Postdiagnosis social networks and breast cancer mortality in the After Breast Cancer Pooling Project.
    Kroenke CH; Michael YL; Poole EM; Kwan ML; Nechuta S; Leas E; Caan BJ; Pierce J; Shu XO; Zheng Y; Chen WY
    Cancer; 2017 Apr; 123(7):1228-1237. PubMed ID: 27943274
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Overall Survival of Men and Women With Breast Cancer According to Tumor Subtype: A Population-based Study.
    Leone J; Zwenger AO; Leone BA; Vallejo CT; Leone JP
    Am J Clin Oncol; 2019 Feb; 42(2):215-220. PubMed ID: 30499840
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison performance of the Bayesian Approach with the Weibull and Birnbaum-Saunders distributions in imputation of time-to-event censors.
    Shahmirzalou P; Rasekhi A; Jafari Khaledi M; Khayamzadeh M
    PLoS One; 2024; 19(1):e0295977. PubMed ID: 38252651
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Standardized breast cancer mortality rate compared to the general female population of Iran.
    Haghighat S; Akbari ME; Ghaffari S; Yavari P
    Asian Pac J Cancer Prev; 2012; 13(11):5525-8. PubMed ID: 23317211
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The SPECTRUM population model of the impact of screening and treatment on U.S. breast cancer trends from 1975 to 2000: principles and practice of the model methods.
    Mandelblatt J; Schechter CB; Lawrence W; Yi B; Cullen J
    J Natl Cancer Inst Monogr; 2006; (36):47-55. PubMed ID: 17032894
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The impact of radiation on early breast carcinoma survival. A Bayesian analysis.
    Levitt SH; Aeppli DM; Nierengarten ME
    Cancer; 1996 Sep; 78(5):1035-42. PubMed ID: 8780541
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasma testosterone and prognosis of postmenopausal breast cancer patients.
    Micheli A; Meneghini E; Secreto G; Berrino F; Venturelli E; Cavalleri A; Camerini T; Di Mauro MG; Cavadini E; De Palo G; Veronesi U; Formelli F
    J Clin Oncol; 2007 Jul; 25(19):2685-90. PubMed ID: 17548841
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Radiotherapy and Male Breast Cancer: A Population-based Registry Analysis.
    Madden NA; Macdonald OK; Call JA; Schomas DA; Lee CM; Patel S
    Am J Clin Oncol; 2016 Oct; 39(5):458-62. PubMed ID: 24781343
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Male breast cancer. Does the prognosis differ compared to female?
    Herman K; Lobaziewicz W; Skotnicki P; Fortuna J; Kusy T; Leśniak T
    Neoplasma; 2000; 47(3):191-5. PubMed ID: 11043845
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of Bayesian network and support vector machine models for two-year survival prediction in lung cancer patients treated with radiotherapy.
    Jayasurya K; Fung G; Yu S; Dehing-Oberije C; De Ruysscher D; Hope A; De Neve W; Lievens Y; Lambin P; Dekker AL
    Med Phys; 2010 Apr; 37(4):1401-7. PubMed ID: 20443461
    [TBL] [Abstract][Full Text] [Related]  

  • 58. EFFECT OF SELECTED PROGNOSTIC AND RISK FACTORS ON SURVIVAL OF WOMEN WITH BREAST CANCER IN GEORGIA.
    Vashakidze N; Mebonia N; Kereselidze M; Gvamichava R; Zhizhilashvili S
    Georgian Med News; 2018 Jun; (279):23-28. PubMed ID: 30035717
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Breast cancer outcomes at the Strathfield Breast Centre.
    Loveridge KH; Kennedy CW; Janu NC; Carmalt HL; Gillett DJ
    Aust N Z J Surg; 1998 Jun; 68(6):411-4. PubMed ID: 9623459
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk factors for stage IV breast cancer at the time of presentation in Turkey.
    Uyeturk U; Tatli AM; Gucuk S; Oksuzoglu B; Ulas A; Avci N; Ozbay MF; Gunduz S; Akinci MB; Salim DK; Sonmez OU; Akdag F; Ergenc H
    Asian Pac J Cancer Prev; 2013; 14(12):7445-9. PubMed ID: 24460317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.